Document is current
Any future updates will be listed below
-
Authors
Conte, Pietro https://orcid.org/0000-0001-5425-0652
Anzillotti, Giuseppe https://orcid.org/0000-0001-9327-5350
Crawford, Dennis C.
Dasa, Vinod
Flanigan, David C.
Nordt, William E.
Scopp, Jason M.
Meislin, Robert J.
Strauss, Eric J.
Strickland, Sabrina M.
Fiorentino, Gennaro
Lattermann, Christian
- License Information
-
More Information
Article History
Received: 30 June 2024
Accepted: 2 September 2024
First Online: 21 September 2024
Declarations
:
: All performed procedures were in accordance with the ethical standards of the institutional and/or national research committees and with the 1964 Helsinki Declaration and its later. The study was registered on clinicaltrials.gov (NCT: 03299959) and approved by the Food and Drug Administration and each site’s Ethics Committees/Institutional Review Boards.
: P Conte, G Anzillotti, G Fiorentino, DC Crawford, RJ Meislin, EJ Strauss, C Latterman and WE Nordt declare they have no financial interests. V Dasa received research and consulting support from Cartiheal, Bioventus, and Smith and Nephew. J Scopp is a consultant with Arthrex. SM Strickland has received consultant honoraria, research support from Smith and Nephew; received speaker and consultant honoraria as well as research support from Miach, Vericel, Moximed. DC Flanigan is a consultant with Smith and Nephew, Conmed, Depuy Synthes, Nanochon, Hyalex, Moximed, Vericel; he receives research support from Smith and Nephew, Conmed, Depuy Synthes, Episurf, Aesculap, KCRN, Moximed, Vericel.
